Bi-allelic EPHA2 mutations cause dysosteosclerosis by inhibiting osteoclastogenesis and enhancing osteoblastogenesis
Xi Chen, Xin Li, Zenghui Gu, Qi Lu, Xinyu Qian, Yier Fan, Ke Deng, Shanshan Li, Zhe Wei, Yang Xu, Wenzhen Fu, Hou-Feng Zheng, Weiwei Hu, Zhenlin Zhang
Springer Nature ·
2026-10-12
· DOI 10.1038/s41413-026-00565-x
⬢ Цитируемость: 0Crossref
Аннотация
Bone Research, Published online: 12 October 2026; doi:10.1038/s41413-026-00565-x Bi-allelic EPHA2 mutations cause dysosteosclerosis by inhibiting osteoclastogenesis and enhancing osteoblastogenesis
Xi Chen, Xin Li, Zenghui Gu, Qi Lu, Xinyu Qian, Yier Fan et al. Bi-allelic EPHA2 mutations cause dysosteosclerosis by inhibiting osteoclastogenesis and enhancing osteoblastogenesis. // Bone Research. – 2026. – DOI: 10.1038/s41413-026-00565-x. – URL: https://www.nature.com/articles/s41413-026-00565-x
Xi Chen, Xin Li, Zenghui Gu, Qi Lu, Xinyu Qian, Yier Fan, Ke Deng, Shanshan Li, Zhe Wei, Yang Xu, Wenzhen Fu, Hou-Feng Zheng, Weiwei Hu, & Zhenlin Zhang (2026). Bi-allelic EPHA2 mutations cause dysosteosclerosis by inhibiting osteoclastogenesis and enhancing osteoblastogenesis. Bone Research. https://doi.org/10.1038/s41413-026-00565-x
Xi Chen, et al. “Bi-allelic EPHA2 mutations cause dysosteosclerosis by inhibiting osteoclastogenesis and enhancing osteoblastogenesis.” Bone Research, 2026. doi:10.1038/s41413-026-00565-x.
@article{Chen2026,
title = {Bi-allelic EPHA2 mutations cause dysosteosclerosis by inhibiting osteoclastogenesis and enhancing osteoblastogenesis},
author = {Chen, Xi and Li, Xin and Gu, Zenghui and Lu, Qi and Qian, Xinyu and Fan, Yier and Deng, Ke and Li, Shanshan and Wei, Zhe and Xu, Yang and Fu, Wenzhen and Zheng, Hou-Feng and Hu, Weiwei and Zhang, Zhenlin},
journal = {Bone Research},
year = {2026},
doi = {10.1038/s41413-026-00565-x},
url = {https://www.nature.com/articles/s41413-026-00565-x}
}